Novartis and Cigna Ventures were part of Cleerly’s $192m series C round while Aptos Labs secured $150m from investors including FTX, Circle and Jump Trading.

BAI Capital is the second Asian venture affiliate of the media group to close a huge fund in the past month, having brought on limited partners including internet and insurance groups.

The professional golfing body has joined forces with sport-focused firm Elysian Park Ventures to launch strategic fund EP Golf Ventures.

Google, Chevron and Sumitomo were part of fusion power system developer TAE’s $250m series G2 while GMO VenturePartners and Christie's Ventures formed new funds.

Eli Lilly and Illumina took part in liquid biopsy developer Delfi Diagnostics' $225m series B round while Sompo, Yamaha Motor and Bridgestone invested $87.8m in driverless vehicle software provider Tier IV.

Bertelsmann vehicle BAI Capital co-led a $150m C2 round for payment card provider Stori while Sram and Mram supplied $100m in series A funding for blockchain ecosystem developer 5ire.

Flow Traders Capital is equipped with over $50m and will invest in digital asset and financial infrastructure technology for its market maker parent.

Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.

Alphabet unit GV participated in autonomous flight technology developer Merlin Labs’ $105m series B round while several corporates helped Cathay Innovation close a $1bn fund.

The newly formed Qlarant Capital will invest up to $2m in healthcare technology startups and is being overseen by Qlarant CEO Ron Forsythe.